# Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury

> **NCT05585255** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 108 (estimated)

## Conditions studied

- Ischemic Stroke, Acute
- Ischemia-reperfusion Injury
- Cerebral Edema

## Interventions

- **DIAGNOSTIC_TEST:** enzyme-linked immunosorbent assay(ELISA)

## Key facts

- **NCT ID:** NCT05585255
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2024-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05585255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05585255, "Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05585255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*